21/11/2024 | Press release | Distributed by Public on 21/11/2024 13:16

Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT α NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American[...]

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Back

 Download the original document